PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,454,604 | -25.7% | 3,418,959 | +2.6% | 0.01% | -23.1% |
| Q2 2023 | $47,716,202 | +206.3% | 3,332,137 | +52.7% | 0.01% | +225.0% |
| Q1 2023 | $15,577,139 | -37.1% | 2,181,672 | -1.2% | 0.00% | -42.9% |
| Q4 2022 | $24,769,821 | +8.1% | 2,207,649 | +6.8% | 0.01% | 0.0% |
| Q3 2022 | $22,912,000 | +32.6% | 2,067,868 | +1.0% | 0.01% | +40.0% |
| Q2 2022 | $17,276,000 | -38.1% | 2,046,806 | -0.1% | 0.01% | -28.6% |
| Q1 2022 | $27,897,000 | -31.4% | 2,049,759 | -0.9% | 0.01% | -30.0% |
| Q4 2021 | $40,666,000 | -36.5% | 2,067,356 | +3.6% | 0.01% | -37.5% |
| Q3 2021 | $64,072,000 | -6.4% | 1,996,016 | -1.3% | 0.02% | -5.9% |
| Q2 2021 | $68,424,000 | -10.2% | 2,021,400 | -0.4% | 0.02% | -15.0% |
| Q1 2021 | $76,208,000 | +11.7% | 2,028,931 | -1.2% | 0.02% | 0.0% |
| Q4 2020 | $68,248,000 | -10.5% | 2,054,438 | -1.2% | 0.02% | -23.1% |
| Q3 2020 | $76,280,000 | +10.6% | 2,080,187 | -0.7% | 0.03% | +4.0% |
| Q2 2020 | $68,960,000 | +28.7% | 2,095,443 | +1.0% | 0.02% | +8.7% |
| Q1 2020 | $53,594,000 | -18.1% | 2,075,685 | -1.3% | 0.02% | +15.0% |
| Q4 2019 | $65,466,000 | – | 2,102,303 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,760,869 | $39,000,212 | 12.45% |
| Frazier Life Sciences Management, L.P. | 10,109,279 | $104,833,223 | 6.96% |
| Decheng Capital Management III (Cayman), LLC | 850,000 | $8,814,500 | 2.94% |
| Carlyle Group Inc. | 3,496,808 | $36,191,963 | 1.57% |
| Ghost Tree Capital, LLC | 395,000 | $4,096,150 | 1.35% |
| Newtyn Management, LLC | 500,000 | $5,185,000 | 1.28% |
| Altium Capital Management LP | 220,000 | $2,281,400 | 1.19% |
| StepStone Group LP | 422,085 | $4,377,021 | 0.98% |
| MPM BioImpact LLC | 347,332 | $3,601,833 | 0.96% |
| NEA Management Company, LLC | 1,276,595 | $12,238,290 | 0.94% |